Teva gets FDA OK for generic of Dey's DuoNeb
Jan 2 (Reuters) - Israel's Teva Pharmaceutical Industries Ltd (TEVA.O) (TEVA.TA) said the U.S. Food and Drug Administration gave final approval for a generic version of Dey L.P.'s bronchodilator, DuoNeb.
Shipment of the inhalation solution will begin immediately, the company said in a statement.
DuoNeb had annual sales of about $265 million in the United States for the 12 months ended Sept. 30, it said quoting IMS sales data.
(Reporting by Bijoy Koyitty; Editing by Gopakumar Warrier)
((bijoy.koyitty@reuters.com; within U.S. +1 646 223 8780; outside U.S. +91 80 4135 5800; Reuters Messaging: bijoy.koyitty.reuters.com@reuters.net)) Keywords: TEVA/FDA
(C) Reuters 2008. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS5475
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters